CytomX Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
CytomX Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2021.
  • CytomX Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2022 was $4.49M, a 31.1% increase year-over-year.
  • CytomX Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2022 was $14.6M, a 6.19% increase year-over-year.
  • CytomX Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $13.2M, a 11% decline from 2020.
  • CytomX Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $14.8M, a 22.6% decline from 2019.
  • CytomX Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $19.1M, a 13.2% increase from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $13.2M -$1.62M -11% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-03-27
2020 $14.8M -$4.31M -22.6% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-03-27
2019 $19.1M +$2.22M +13.2% Jan 1, 2019 Dec 31, 2019 10-K/A 2023-03-27
2018 $16.9M +$5.59M +49.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $11.3M +$1.19M +11.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $10.1M +$6.11M +153% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $3.99M +$3.43M +621% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 $553K +$210K +61.2% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2013 $343K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.